Artificial Intelligence
NEW YORK – Artificial intelligence company Nucleai and Jefferson Health on Tuesday announced a collaboration to discover histological biomarkers that predict response to immunotherapy. Tel Aviv-based Nucleai will use its ATOM platform to...
Symposium | Pathologist-led Development of Deep Learning Models for...
Register Now AIRA Matrix invites you to a symposium on the development and validation of Deep Learning algorithms for the detection and quantification of the major features of Progressive Cardiomyopathy (PCM) in rodents. Rodent PCM...
WESTBURY, N.Y. — BioIVT’s ASTERAND® Human Tissue Repository contains clinical data from more than one million biospecimens and can be mined to reveal patterns and relationships in disease etiology and pathology. BioIVT, a leading...
MOUNTAIN VIEW, Calif., Sept. 10, 2021 -- Crosscope, a leading AI software provider in digital pathology is collaborating with NINGBO KONFOONG BIOINFORMATION TECH CO.,LTD. (KFBIO) an innovative high-tech cutting edge Whole slide imaging...
Swifter discovery can improve life expectancy A longer life expectancy goes hand in hand with the risk of cancer. The Hamburg-based Mindpeak is developing artificial intelligence to help pathologists diagnose cancer swiftly. Until now,...
It enables every actor in Pathology to run digital image analysis in the context of clinical trials, as in CAP/CLIA laboratories, with unprecedented efficiency. This AI-platform strengthens Keen Eye's strategic positioning in the clinical...
